Evidence indicating that the extracellular loops of the mouse MC5 receptor do not participate in ligand binding

Molecular and Cellular Endocrinology

Volumn 139, Issue 1-2, 1998, Pages 109-115

  Schiöth, Helgi B ^a   Fredriksson, Ann ^a   Carlsson, Cecilia ^a   Yook, Philip ^a   Muceniece, Ruta ^b   Wikberg, Jarl E S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Ligand binding; Mouse MC5 receptor; MSH; Mutagenesis

Indexed keywords

INTERMEDIN; MELANOCORTIN RECEPTOR; MUTANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; GENE LIBRARY; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION;

EID: 0344784401     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00067-7     Document Type: Article

References (42)

1. Cammas F.M., Kapas S., Barker S., Clark A.J.L. Cloning, characterization and expression of a functional mouse ACTH receptor. Biochem. Biophys. Res. Comm. 212:1995;912-918.
2. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell. 91:1997;789-798.
3. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
4. Chhajlani V., Muceniece R., Wikberg J.E.S. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 195:1993;866-873.
5. Chhajlani V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem. Mol. Biol. Int. 38:1996;73-80.
6. Eberle, A.N., 1988. The Melanotropins; Chemistry, Physiology and Mechanisms of Action. Karger, Basel, Switzerland.
7. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
8. Fathi Z., Iben L.G., Parker E.M. Cloning, expression and tissue distribution of a fifth melanocortin receptor subtype. Neurochem. Res. 20:1995;107-113.
9. Fong T.M., Huang R.R., Strader C.D. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem. 267:1992;25664-25667.
10. Frändberg P.A., Xu X., Chhajlani V. Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH. Biochem. Biophys. Res. Commun. 236:1997;489-492.
11. Frändberg P.A., Muceniece R., Prusis P., Wikberg J.E.S., Chhajlani V. Evidence for a alternative points of attachment for α-MSH and its stereoisomer NDP-MSH at the melanocortin 1 receptor. Biochem. Biophys. Res. Commun. 202:1994;1266-1271.
12. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268:1993a;8246-8250.
13. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., DelValle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268:1993b;15174-15179.
14. Haskell-Luevano C., Sawyer T.K., Trumpp-Kallmayer S., Bikker J.A., Humblet C., Gantz I., Hruby V.J. Three dimentional models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Drug Des. Discov. 14:1996;197-211.
15. Holtman M.H., Hadac E.M., Miller L.J. Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J. Biol. Chem. 270:1995;14394-14398.
16. Huang R.R., Vicario P.P., Strader C.D., Fong T.M. Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry. 34:1995;10048-10055.
17. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
18. Koppula S.V., Robbins L.S., Lu D., Baack E., White Jr C.R., Swansson N.A., Cone R.D. Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects. Hum. Mutat. 9:1997;30-36.
19. Labbé O., Desarnaud F., Eggerickx D., Vassart G., Parmentier M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry. 33:1994;4543-4549.
20. Landt O., Grunert H.-P., Hahn U. A general method for rapid site-directed mutagenesis using the polymerase chain reaction. Gene. 96:1990;125-128.
21. Marklund L., Johanssson-Möller M., Sandberg K., Andersson L. A missense mutation in the gene for melanocyte-stimulating hormone receptor (MC1R) is associated with the chestnut coat color in horses. Mamm. Genome. 7:1996;895-899.
22. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
23. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in endocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994a;1298-1308.
24. Mountjoy K.G. The human melanocyte stimulating hormone receptor has evolved to become 'super-sensitive' to melanocortin peptides. Mol. Cell. Endocrinol. 102:1994b;R7-R11.
25. O'Donahue T.L., Dorsa D.M. The opiomelanotropinergic neuronal and endocrine systems. Peptides. 3:1982;353-395.
26. Prusis P., Frändberg P.A., Muceniece R., Kalvinsh I., Wikberg J.E.S. A three dimentional model for the interaction of MSH with the melanocortin 1 receptor. Biochem. Biophys. Res. Commun. 210:1995;205-210.
27. Rajora N., Boccoli G., Burns D., Sharma S., Catania A.P., Lipton J.M. Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J. Neurosci. 15:1997;2181-2186.
28. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rehfuss L., Baack E., Mountjoy K.G., Cone R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72:1993;827-834.
29. 7]α-melanocyte stimulating hormone; A highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. USA. 77:1980;5754-5758.
30. Schiöth H.B., Muceniece R., Wikberg J.E.S., Chhajlani V. Characterisation of melanocortin receptor subtypes by radioligand binding analysis. Eur. J. Pharmacol. Mol. Pharm. Sect. 288:1995;311-317.
31. Schiöth H.B., Muceniece R., Wikberg J.E.S. Characterisation of melanocortin 4 receptor by radioligand binding analysis. Pharmacol. Toxicol. 79:1996a;161-165.
32. Schiöth H.B., Chhajlani V., Muceniece R., Klusa V., Wikberg J.E.S. Major pharmacological distinction of the ACTH receptor from the other melanocortic receptors. Life Sci. 59:1996b;797-801.
33. Schiöth H.B., Muceniece R., Szardenings M., Prusis P., Wikberg J.E.S. Evidence indicating that the TM4, EL2, and TM5 of the melanocortin 3 receptor do not participate in ligand binding. Biochem. Biophys. Res. Commun. 229:1996c;687-692.
34. Schiöth H.B., Muceniece R., Wikberg J.E.S., Szardenings M. Alternative translation initiation codon for the human melanocortin MC3 receptor does not affect the ligand binding. Eur. J. Pharmacol. 314:1996d;381-384.
35. Schiöth H.B., Muceniece R., Prusis P., Szardenings M., Lindeberg G., Sharma S.D., Hruby V.J., Wikberg J.E.S. Characterisation of D117A and H260A mutations in the melanocortin 1 receptor. Mol. Cell. Endocrinol. 126:1997a;213-219.
36. Schiöth H.B., Petersson S., Muceniece R., Szardenings M., Wikberg J.E.S. Deletions of the N-terminal regions of the human melanocortin receptors. FEBS Lett. 410:1997b;223-228.
37. Shire D., Calandra B., Delpech M., Dumont X., Kagdad M., Le Fur G., Cuput D., Ferrara P. Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J. Biol. Chem. 271:1996;6941-6946.
38. Våge D.I., Lu D., Klungland H., Lien S., Adalsteinsson S., Cone R.D. A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat. Genet. 15:1997;311-315.
39. Valverde P., Healy E., Jacksson I., Rees J.L., Thody A.J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11:1995;328-330.
40. Xia Y., Skoog V., Muceniece R., Chhajlani V., Wikberg J.E.S. Polyclonal antibodies against human melanocortin MC1 receptor: preliminary immunohistochemical localisation of melanocortin MC1 receptor to malignant melanoma cells. Eur. J. Pharmacol. 15:1995a;277-283.
41. Xia Y., Wikberg J.E.S., Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport. 6:1995b;2193-2196.
42. Xu X., Thörnwall M., Lundin L-G., Chhajlani V. Val92Met variant of the melanocyte stimulating hormone receptor gene. Nat. Genet. 14:1996;364.